Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

YD Bio Ltd (YDES)

NGM · Biotechnology

$2.30+0.01 (+0.44%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$162.9M
P/E (TTM)
EPS
$-0.12
Div Yield
52W Range
$1.70–$25.00
Beta
-0.13

Company overview

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.

Peers in Biotechnology

All in industry →

Recent press releases

YD Bio Ltd has not issued a press release in this window.

SEC filings

All filings →

YD Bio Ltd has not filed an SEC document in this window.

YD Bio Ltd has no reported insider trades in the last 90 days.

Institutional holders

All holders →

No 13F holdings have been reported for YD Bio Ltd in this window.

People at YD Bio Ltd

All people →

Quarterly financials

Full financials →

No quarterly financials have been ingested for YD Bio Ltd.